6ZWO image
Entry Detail
PDB ID:
6ZWO
EMDB ID:
Keywords:
Title:
cryo-EM structure of human mTOR complex 2, focused on one half
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2020-07-28
Release Date:
2020-11-18
Method Details:
Experimental Method:
Resolution:
3.00 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Serine/threonine-protein kinase mTOR
Chain IDs:A (auth: B)
Chain Length:2549
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Target of rapamycin complex subunit LST8
Chain IDs:B (auth: D)
Chain Length:326
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Rapamycin-insensitive companion of mTOR
Chain IDs:C (auth: F)
Chain Length:1708
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Target of rapamycin complex 2 subunit MAPKAP1
Chain IDs:D (auth: H)
Chain Length:521
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
The 3.2- angstrom resolution structure of human mTORC2.
Sci Adv 6 ? ? (2020)
PMID: 33158864 DOI: 10.1126/sciadv.abc1251

Abstact

The protein kinase mammalian target of rapamycin (mTOR) is the central regulator of cell growth. Aberrant mTOR signaling is linked to cancer, diabetes, and neurological disorders. mTOR exerts its functions in two distinct multiprotein complexes, mTORC1 and mTORC2. Here, we report a 3.2-Å resolution cryo-EM reconstruction of mTORC2. It reveals entangled folds of the defining Rictor and the substrate-binding SIN1 subunits, identifies the carboxyl-terminal domain of Rictor as the source of the rapamycin insensitivity of mTORC2, and resolves mechanisms for mTORC2 regulation by complex destabilization. Two previously uncharacterized small-molecule binding sites are visualized, an inositol hexakisphosphate (InsP6) pocket in mTOR and an mTORC2-specific nucleotide binding site in Rictor, which also forms a zinc finger. Structural and biochemical analyses suggest that InsP6 and nucleotide binding do not control mTORC2 activity directly but rather have roles in folding or ternary interactions. These insights provide a firm basis for studying mTORC2 signaling and for developing mTORC2-specific inhibitors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures